The PFO anatomy evaluation as possible tool to stratify the associated risks and the benefits arising from the closure

European Journal of Echocardiography

Volumn 11, Issue 6, 2010, Pages 488-491

  Fazio, Giovanni ^a   Ferro, Giovanni ^a   Carità, Patrizia ^a   Lunetta, Monica ^a   Gullotti, Alessandro ^a   Trapani, Renato ^a   Fabbiano, Adele ^a   Novo, Giuseppina ^a   Novo, Salvatore ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cerebrovascular event; Closure; Ictus; Migraine with aura; PFO; Prognostic value

Indexed keywords

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; EVALUATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE WITH AURA; PATENT FORAMEN OVALE; PRIORITY JOURNAL; PROGNOSIS; RISK BENEFIT ANALYSIS; SURGICAL ANATOMY; VALSALVA MANEUVER;

ADULT; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; ECHOCARDIOGRAPHY; FEMALE; FORAMEN OVALE, PATENT; HUMANS; ITALY; MALE; MIDDLE AGED; MIGRAINE WITH AURA; MULTIVARIATE ANALYSIS; ODDS RATIO; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; VALSALVA MANEUVER;

EID: 77955881500     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jeq003     Document Type: Article

References (46)

1. Wu LA, Malouf JF, Dearani JA. Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med 2004;164: 950-956
2. Wahl A, Windecker S, Meier B. Patent foramen ovale: pathophysiology and therapeutic options in symptomatic patients. Minerva Cardioangiol 2001;49:403-411
3. Schrader R. Indication and techniques of transcatheter closure of patent foramen ovale. J Interv Cardiol 2003;16:543-551
4. Sacco RL, Ellemberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR. Infarcts of undetermined cause: the NINCDS stroke data bank. Ann Neurol 1989;25:382-390
5. Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation 2005;112: 1063-1072
6. Kerut EK, Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001; 38:613-623
7. Rigatelli G, Dell'Avvocata F, Giordan M, Braggion G, Aggio S, Chinaglia M et al. Embolic implications of combined risk factors in patients with patent foramen ovale (the CARPE criteria): consideration for primary prevention closure? J Interv Cardiol 2009;22:398-403. Epub June 8, 2009.
8. Goel SS, Tuzcu EM, Shishehbor MH, de Oliveira EI, Borek PP, Krasuski RA et al. Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. Am J Cardiol 2009;103:124-129 Epub October 30, 2008.
9. Aubry P, Gérardin B, Juliard JM, Tchetche D, Brochet E, Etchegoyen L et al. Patent foramen ovale percutaneous closure: indications, techniques and results. Ann Cardiol Angeiol (Paris) 2007;56:275-282
10. Schräder R. Indication and techniques of transcatheter closure of patent foramen ovale. J Interv Cardiol 2003;16:543-551
11. Mareedu RK, Shah MS, Mesa JE, McCauley CS. Percutaneous closure of patent foramen ovale: a case series and literature review. Clin Med Res 2007;5:218-226
12. Goel SS, Tuzcu EM, Shishehbor MH, de Oliveira EI, Borek PP, Krasuski RA et al. Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. Am J Cardiol 2009;103:124-129
13. Natanzon A, Goldman ME. Patent foramen ovale: anatomy versus pathophysiology- which determines stroke risk? J Am Soc Echocardiogr 2003;16:71-76
14. De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000;31:2407-2413
15. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G et al., Patent Foramen Ovale Atrail Septal Aneurism Study GroupRecurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746
16. Force M, Massabuau P, Larrue V. Prevalence of atrial septal abnormalities in older patients with cryptogenic ischemic stroke or transient ischemic attack. Clin Neurol Neurosurg 2008;110:779-783
17. Rigatelli G, Dell'avvocata F, Cardaioli P, Giordan M, Braggion G, Aggio S et al. Migraine-patent foramen ovale connection: role of prominent eustachian valve and large Chiari network in migrainous patients. Am J Med Sci 2008;336:458-461
18. Rigatelli G, Dell'avvocata F, Braggion G, Giordan M, Chinaglia M, Cardaioli P. Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: an intracardiac echocardiographic study. Catheter Cardiovasc Interv 2008;72:973-976
19. Magalhães E, Torreão J, Costa N, Freitas N, Melo A. Role of patent foramen ovale and of the Eustaquian valve in the trhomboembolic events. Arq Neuropsiquiatr 2006;64:245-248
20. Schuchlenz HW, Saurer G, Weihs W, Rehak P. Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events. J Am Soc Echocardiogr 2004;17:231-233
21. Norfleet WT, Plotnick GD, Giles TD. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001;38: 613-623
22. Schuchlenz HW, Weihs W, Horner S, Quehenberger F. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 2000;109:456-462
23. Steiner MM, Di Tullio MR, Rundek T, Gan R, Chen X, Liguori C et al. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998;29:944-948
24. Rigatelli G, Cardaioli P, Dell'Avvocata F, Giordan M, Braggion G, Aggio S et al. The association of different right atrium anatomical-functional characteristics correlates with the risk of paradoxical stroke: an intracardiac echocardiographic study. J Interv Cardiol 2008;21:357-362
25. Sievert H, Horvath K, Zadan E, Krumsdorf U, Fach A, Merle H et al. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Interv Cardiol 2001;14:261-266
26. Telman G, Yalonetsky S, Kouperberg E, Sprecher E, Lorber A, Yarnitsky D. Size of PFO and amount of microembolic signals in patients with ischaemic stroke or TIA. Eur J Neurol 2008;15:969-972
27. McKenzie JA, Edwards WD, Hagler DJ. Anatomy of the patent foramen ovale for the interventionalist. Catheter Cardiovasc Interv 2009;73:821-826
28. Steinberg DH, Pichard AD, Satler LF, Slack MC, Wunderlich N, Majunke N. Sievert H1 patent foramen ovale closure: past, present and future. Expert Rev Cardiovasc Ther 2007;5:881-891
29. Bailey CE, Allaqaband S, Bajwa TK. Current management of patients with patent foramen ovale and cryptogenic stroke: our experience and review of the literature. WMJ 2004;103:32-36
30. Slottow TL, Steinberg DH. Waksman overview of the 2007 Food and Drug Administration Circulatory System Devices Panel meeting on patent foramen ovale closure devices. Circulation 2007;116:677-682
31. Tepper SJ, Sheftell FD, Bigal ME. Patent foramen ovale-migraine question. Neurol Sci 2007;28:S118-S123.
32. Domitrz I, Mieszkowski J, Kamińska A. Relationship between migraine and patent foramen ovale: a study of 121 patients with migraine. Headache 2007;47:1311-1318
33. Cuadrado ML, Pareja JA. Patent foramen ovale and migraine: where is the connection. Neurologia 2008;23:475-483
34. Spies C, Kavinsky CJ, Schräder R. Patent foramen ovale in patients with migraine headache. Should it be closed? Minerva Med 2007;98:25-36.
35. Spies C, Schräder R. Transcatheter closure of patent foramen ovale in patients with migraine headache. J Interv Cardiol 2006;19:552-557
36. Schwerzmann M, Nedeltchev K, Meier B. Patent foramen ovale closure: a new therapy for migraine. Catheter Cardiovasc Interv 2007;69:277-284 (Pubitemid 46214264)
37. Zito C, Dattilo G, Oreto G, Di Bella G, Lamari A, Iudicello R et al. Patent foramen ovale: comparison among diagnostic strategies in cryptogenic stroke and migraine. Echocardiography 2009;26:495-503.
38. Schwerzmann M, Nedeltchev K, Lagger F, Mattle HP, Windecker S, Meier B et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005;65:1415-1418
39. Vigna C, Marchese N, Inchingolo V, Giannatempo GM, Pacilli MA, Di Viesti P et al. Improvement of migraine after patent foramen ovale percutaneous closure in patients with subclinical brain lesions: a case-control study. JACC Cardiovasc Interv 2009;2:107-113
40. Chen W-J, Kuan P, Lien W-P, Lin FY. Detection of patent foramen ovale by contrast transesophageal echocardiography. Chest 1992;101:1515-1520
41. Martin-Reyes R, López-Fernández T, Moreno-Yangüela M, Moreno R, Navas-Lobato MA, Refoyo E et al. Role of real-time three-dimensional transoesophageal echocardiography for guiding transcatheter patent foramen ovale closure. Eur J Echocardiogr 2009;10:148-150
42. Droste DW, Schmidt-Rimpler C, Wichter T, Dittrich R, Ritter M, Stypmann J et al. Right-to-left-shunts detected by transesophageal echocardiography and transcranial Doppler sonography. Cerebrovasc Dis 2004;17:191-196
43. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
44. Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus JL, Karnicki K et al. Patent foramen ovale: standards for a preclinical model of prevalence, structure, and histopathologic comparability to human hearts. Catheter Cardiovasc Interv 2007;69: 266-273
45. Gaspardone A, Iani C, Papa M. Percutaneous closure of patent foramen ovale: a wise approach. G Ital Cardiol (Rome) 2008;9:593-602.
46. Kutty S, Brown K, Qureshi AM, Latson LA. Maximal potential patent foramen diameter does not correlate with the type or frequency of the neurologic event prior to closure. Cardiology 2009;113:111-115